Australia, March 31 -- ADARX PHARMACEUTICALS Inc., owns the trademark (2613396) for 'ADARX PHARMACEUTICALS' till Aug. 28, 2035.
Status: protected:
Registered/protected
Classes: 1 [Chemical compounds in the nature of nucleotides for scientific and research use; chemical compounds in the nature of nucleotides for use in the manufacture of pharmaceuticals.], 5 [Pharmaceutical preparations, namely, RNA-based therapeutics for use in the treatment of complement-mediated, immune-related, genetic, cardiovascular, central nervous system, and metabolic diseases, conditions, and disorders, and cancer.] and 42 [Development of pharmaceutical preparations and medicines; pharmaceutical products development; pharmaceutical research and development; scien...